Life Sciences Strategy Summit in IP & Exclusivity

We are pleased having been a Gold Sponsor of the Life Sciences Strategy Summit in IP & Exclusivity.

Dr Eva Ehlich and Dr Annelie Wünsche spoke a roundtable on “Freedom to Operate – Analysis and Search Strategy”.

The Life Science Strategy Summit on IP & Exclusivity returned to Munich this October. The premier life science IP event gathered the leading legal professionals working in biopharma for 3 days practical discussion on practical and industry-led patent strategy, patent prosecution and market exclusivity topics.

The first meeting following the launch of the Unified Patent Court (UPC), joined the leading community of life science patent professionals to understand the industry’s reaction to the new court system and have candid discussions with the European life science intellectual property experts.

For more information on this event, please click here.